PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 17 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $302,000 | -23.5% | 83,500 | -28.0% | 0.04% | -31.4% |
Q3 2019 | $395,000 | -27.5% | 116,000 | 0.0% | 0.05% | +34.2% |
Q2 2019 | $545,000 | -44.3% | 116,000 | -60.3% | 0.04% | -15.6% |
Q1 2019 | $979,000 | +2.2% | 292,500 | -18.8% | 0.04% | -31.8% |
Q4 2018 | $958,000 | +24.3% | 360,343 | +161.6% | 0.07% | +50.0% |
Q3 2018 | $771,000 | -18.1% | 137,748 | -25.8% | 0.04% | -20.0% |
Q2 2018 | $941,000 | +1263.8% | 185,700 | +514.9% | 0.06% | +511.1% |
Q4 2015 | $69,000 | – | 30,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 3,196,527 | $16,526,000 | 3.00% |
BVF INC/IL | 5,328,239 | $27,547,000 | 1.08% |
Soleus Capital Management, L.P. | 740,000 | $3,826,000 | 0.60% |
Cutter & CO Brokerage, Inc. | 326,100 | $1,686,000 | 0.40% |
EAM Investors, LLC | 288,459 | $1,491,000 | 0.25% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $5,316,000 | 0.15% |
Rhenman & Partners Asset Management AB | 300,000 | $1,551,000 | 0.11% |
Navis Wealth Advisors, LLC | 16,000 | $83,000 | 0.06% |
Sigma Planning Corp | 364,484 | $1,884,000 | 0.06% |
XTX Topco Ltd | 32,650 | $169,000 | 0.06% |